Microglia are the brain’s resident immune cells, a specialized population that accounts for roughly 5 to 15 percent of all cells in the central nervous system. They constantly monitor the brain’s environment, clear debris, sculpt neural circuits during development, and mount the first line of defense against infection or injury. What makes them unusual is that they are not born from the same precursor cells as the neurons and other glia around them; they originate outside the brain entirely and take up permanent residence early in embryonic life. That dual identity, part immune sentinel and part neural caretaker, is what makes microglia so central to brain health and so implicated when things go wrong.
Where Microglia Come From
Unlike neurons and astrocytes, which arise from neural stem cells, microglia descend from immune cell precursors that originate in the yolk sac during early embryonic development. These primitive macrophage precursors migrate into the developing brain before the blood-brain barrier fully forms, and once inside, they settle in and become a self-sustaining population.1PubMed. Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain This makes microglia fundamentally different from the circulating immune cells that patrol the rest of the body. Blood-borne macrophages and monocytes can enter the brain under extreme conditions like injury or disease, but under normal circumstances, the microglial population maintains itself through local self-renewal rather than being replenished from the bloodstream.2Frontiers in Cellular Neuroscience. Origin and differentiation of microglia
This yolk-sac origin was a surprising discovery. For decades, researchers assumed microglia were simply brain-resident macrophages that arrived from bone marrow. Fate-mapping studies in mice eventually overturned that idea, showing that microglia seed the brain during embryonic development and then proliferate in place throughout life without needing reinforcement from outside. A key signaling pathway involving the colony-stimulating factor 1 receptor governs this self-renewal process; blocking that receptor depletes microglia, and restoring it allows the population to bounce back.3PubMed Central. CSF1R-Dependent Microglial Repopulation and Contact-Dependent Inhibition of Proliferation In Vitro
Constant Surveillance of the Brain
Even when the brain is healthy and nothing seems to be happening, microglia are anything but idle. They extend and retract long, branching processes that sweep through the surrounding tissue, sampling the local environment on a scale of minutes. This surveillance is so thorough that a given patch of brain tissue can be surveyed every few hours.4PubMed. Nanoscale Surveillance of the Brain by Microglia via cAMP-Regulated Filopodia The processes are not just passively drifting. They carry fine, hair-like extensions called filopodia that probe at even finer resolution, making contact with synapses, blood vessels, and neighboring cells. If something is off, whether a neuron is stressed, a pathogen has entered, or a synapse is misfiring, microglia can detect the chemical signals and rapidly shift from surveillance mode to a reactive state.
This resting-but-vigilant posture is sometimes called the “homeostatic” state. Microglia in this mode have a distinctive shape: a small cell body with many thin, branching arms radiating outward. When they detect trouble, they pull in those branches, enlarge their cell body, and begin producing inflammatory molecules or engulfing debris. The speed of that transformation is part of what makes microglia effective. They are already distributed throughout the brain, already sampling, already positioned to act.
Pruning Synapses During Development
One of the more remarkable things microglia do has nothing to do with fighting infection. During brain development, the nervous system initially overproduces synaptic connections between neurons. Many of these connections are weak, redundant, or incorrectly wired, and they need to be removed for circuits to function properly. Microglia carry out much of this pruning.
The process works through a tagging system borrowed from the immune system called the complement cascade. Complement proteins, particularly C1q, C3, and C4, mark specific synapses for removal. Microglia, which are in a highly phagocytic state during the pruning period, recognize those tags and physically engulf the marked synapses.5PubMed. Complement System in Neural Synapse Elimination in Development and Disease The complement components involved in this process also contribute to refining synaptic circuits during later periods of brain plasticity in adulthood.6PubMed Central. The Role of Complement in Synaptic Pruning and Neurodegeneration
When this system misfires, the consequences can be serious. Excessive pruning has been linked to neurodevelopmental conditions. Researchers increasingly view disorders like autism spectrum disorder and schizophrenia not as entirely separate conditions but as points on a shared neurodevelopmental continuum where altered synaptic connectivity and immune dysregulation overlap. Microglia sit at the intersection of those processes because of their dual roles in circuit remodeling and immune surveillance.7PubMed Central. A vicious cycle of microglial dysfunction: bridging synaptic pruning and neuroinflammation across the neurodevelopmental continuum
Taking Out the Trash
Beyond pruning synapses, microglia serve as the brain’s primary cleanup crew. When neurons die through the normal process of programmed cell death, or when cellular debris accumulates from injury or disease, microglia engulf and digest the material. This phagocytic function prevents dead-cell contents from leaking into surrounding tissue and triggering harmful inflammation.
Microglia recognize dying cells through a set of surface signals. A key one involves phosphatidylserine, a molecule that flips to the outer surface of a cell’s membrane when that cell is undergoing programmed death. This “eat me” signal, along with other surface markers, is detected by multiple receptor systems on microglia.8PubMed. Phagocytic clearance of apoptotic neurons by Microglia/Brain macrophages in vitro: involvement of lectin-, integrin-, and phosphatidylserine-mediated recognition The recognition mechanism is surprisingly specific. Dying neurons do not release attractant signals to call microglia over from a distance; instead, microglia encounter them during their routine surveillance sweeps and respond to the combination of surface signals once they make contact.9Frontiers in Cellular Neuroscience. Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis
Feeding and Protecting Neurons
Microglia do not just remove things; they also actively support the growth of new neurons, at least in certain brain regions. During early postnatal development, microglia in areas where new neurons are being born release signaling molecules, including several cytokines, that promote the production and survival of neural precursor cells.10PubMed Central. Neuroprotective function of microglia in the developing brain This neurotrophic role is less well-studied than their immune functions, but it underscores the fact that categorizing microglia purely as “brain immune cells” sells them short. They are integral to building the brain in the first place.
Microglia also coordinate closely with astrocytes, the other major class of glial cells. Together, they influence each other’s behavior and collectively manage the brain’s internal environment, including maintaining the blood-brain barrier and supporting synaptic function.11PubMed Central. Microglia and Astrocyte Function and Communication: What Do We Know in Humans? This crosstalk matters because it means microglial dysfunction does not stay contained. When microglia become chronically activated, the signals they send to astrocytes can push those cells into a harmful state too, amplifying damage.
Microglia in Alzheimer’s Disease
Perhaps no disease has put microglia under more scrutiny than Alzheimer’s. One of the strongest genetic risk factors for late-onset Alzheimer’s is a variant of a gene called TREM2, which encodes a receptor found on the surface of microglia. TREM2 helps microglia cluster around amyloid-beta plaques and clear them. In mouse models, losing even one functional copy of the TREM2 gene is enough to increase amyloid accumulation and worsen neuronal damage.12Cell. Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Is a Receptor for Damages-Associated Lipids that Enhance Amyloid-β Accumulation
The problem is that the same complement-dependent pruning machinery microglia use during development appears to get reactivated inappropriately in Alzheimer’s. Instead of trimming excess synapses in a young brain, the system begins tagging and destroying healthy synapses in an aging one. Research in Alzheimer’s mouse models has shown that complement and microglia mediate early synapse loss, and that blocking this pathway can reduce that loss.13PubMed Central. Complement and microglia mediate early synapse loss in Alzheimer mouse models The implication is provocative: the same mechanism that fine-tunes circuits in childhood may contribute to cognitive decline decades later.
Microglia in Parkinson’s and Other Neurodegenerative Diseases
Alzheimer’s is not the only neurodegenerative condition where microglia play a central role. In Parkinson’s disease, microglia shift from their homeostatic state to a persistently pro-inflammatory one. When that inflammatory phenotype does not resolve, it contributes to the progressive loss of dopamine-producing neurons that defines the disease.14PubMed Central. Microglia Mediated Neuroinflammation in Parkinson’s Disease A similar pattern of chronic microglial activation has been implicated in multiple sclerosis, amyotrophic lateral sclerosis, and other conditions where neuroinflammation is a driving feature.
Distinguishing microglia from blood-derived macrophages that infiltrate the brain during disease has been a long-standing technical challenge. The two cell types look similar under a microscope and share many surface markers. Recent work has identified gene signatures that are unique to each population, even during active neuroinflammation. For instance, the TREM-1 protein, a relative of the TREM2 involved in Alzheimer’s, is expressed by infiltrating macrophages but not by resident microglia at the peak of brain inflammation.15PubMed Central. Differential transcriptional profiles identify microglial- and macrophage-specific gene markers expressed during virus-induced neuroinflammation Being able to tell them apart matters for therapy, because targeting the wrong population could leave the real culprit untouched or suppress a beneficial response.
How Aging Changes Microglia
Even without a diagnosed disease, microglia change as the brain ages. In older brains, microglia take on a more inflammatory baseline profile: they express higher levels of inflammatory markers, produce fewer protective factors, and their physical shape shifts toward a dystrophic morphology with shorter, more fragmented branches.16PubMed Central. Microglia Priming with Aging and Stress Researchers describe this state as “primed,” meaning the microglia are not actively causing damage on their own, but they are poised to overreact to any provocation. An infection, a head injury, or even psychological stress that would provoke a measured immune response in a young brain can trigger an exaggerated inflammatory reaction in an aged one.17PubMed Central. Review: microglia of the aged brain: primed to be activated and resistant to regulation
This priming may help explain why older adults recover more slowly from brain injuries and why neurodegenerative diseases are overwhelmingly diseases of aging. The microglia are not just passive bystanders. They are actively shifting the brain’s immune environment toward one where damage is more easily amplified and less easily repaired.
Microglia and Chronic Pain
Microglia are not confined to the brain proper. They also populate the spinal cord, and there they play a surprisingly important role in chronic pain. After a peripheral nerve injury, microglia in the spinal cord become activated and begin expressing a receptor called P2X4. When stimulated, this receptor drives the release of brain-derived neurotrophic factor (BDNF), which alters the behavior of pain-transmitting neurons in the spinal cord.18PubMed Central. Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain The result is that normally harmless sensations begin to register as painful, a hallmark of neuropathic pain.
Mice lacking the P2X4 receptor do not develop this mechanical hypersensitivity after nerve injury, and their BDNF signaling in the spinal cord is impaired.19PubMed Central. Brain-derived neurotrophic factor from microglia: a molecular substrate for neuropathic pain This discovery has opened up the possibility of targeting spinal microglia specifically to treat chronic pain conditions that do not respond well to traditional painkillers. It is also a vivid example of how microglia can be both protective and harmful depending on the context: the same cell type that clears debris and supports developing neurons can also amplify pain signals when its activation goes unchecked.
Guarding the Blood-Brain Barrier
A subset of microglia physically wrap themselves around the tiny capillaries that thread through the brain. These capillary-associated microglia sit at the boundary between the brain’s internal environment and the bloodstream, and they appear to help maintain the integrity of the blood-brain barrier. They interact with endothelial cells, pericytes, astrocytes, and neurons, functioning as a kind of immunological checkpoint at the vascular interface.20PubMed Central. Capillary-Associated Microglia in Neurovascular Coupling: Localization, Mechanisms, and Disease Implications This vascular role is relatively newly appreciated and adds yet another dimension to what was already a surprisingly versatile cell type.
Hijacked by Tumors
Brain tumors, particularly glioblastoma, exploit microglia in a way that is almost devious. Glioblastoma-initiating cells activate a signaling pathway in microglia that pushes them toward an immunosuppressive state. In this altered state, microglia actively help the tumor evade the immune system by blocking the entry and activity of the T cells that would normally attack the cancer.21PubMed Central. Microglia promote glioblastoma via mTOR-mediated immunosuppression of the tumour microenvironment In effect, the tumor turns the brain’s own immune cells into collaborators. Understanding this hijacking is one of the reasons glioblastoma remains so difficult to treat and why researchers are exploring ways to reprogram tumor-associated microglia back into a tumor-fighting state.
Sex Differences in Microglial Biology
Microglia are not identical in male and female brains. They differ in their shape, their gene expression profiles, and how aggressively they respond to inflammatory triggers.22PubMed Central. Sex differences in microglia morphology and function across the lifespan are mediated by the early hormone environment These sex differences are established early, shaped in part by the hormonal environment during development, and they persist across the lifespan. The differences are not trivial: they may help explain why certain neurodegenerative diseases strike men and women at different rates and with different severity.23PubMed Central. Do Microglial Sex Differences Contribute to Sex Differences in Neurodegenerative Diseases? Alzheimer’s disease, for example, is more common in women, while Parkinson’s disease is more common in men, and microglia are increasingly seen as one piece of that puzzle.
The Gut Connection
One of the more surprising recent findings about microglia involves the gut. The community of microbes living in the intestinal tract appears to influence how microglia mature and function in the brain. Preclinical research has shown that animals raised without gut bacteria have microglia that are immature and less responsive. When a normal microbial community is restored, microglial function recovers.24PubMed Central. Microbiome-microglia connections via the gut-brain axis Altered gut microbiome composition has also been reported in neurological disorders where microglial involvement is known, though the direction of causality remains an active area of research. It is an intriguing link that connects intestinal health to brain immune function through a route nobody would have predicted a few decades ago.
Microglia Run on a Clock
Microglial activity is not constant throughout the day. These cells follow circadian rhythms, changing their shape and gene expression depending on the time. In the cortex, microglia take on a more compact, highly branched form during waking hours and a less complex shape during sleep. Their expression of key molecules, including enzymes involved in remodeling the spaces around synapses, peaks in the early hours of the active phase.25PubMed. Microglial circadian clock regulation of microglial structural complexity, dendritic spine density and inflammatory response Disruptions to the microglial circadian clock, whether from amyloid-beta exposure or chronic sleep loss, can push microglia toward a more inflammatory profile. This offers one possible explanation for why poor sleep is consistently associated with increased risk for neurodegenerative disease.
Therapeutic Approaches Targeting Microglia
Given how many diseases involve dysfunctional microglia, the obvious question is whether you can fix the problem by replacing them. The field is exploring exactly that. Because microglia depend on colony-stimulating factor 1 receptor signaling to survive, drugs that block this receptor can wipe out most of the microglial population in the brain. Once the drug is withdrawn, the empty niche is repopulated by new microglia that arise from remaining precursors, and these fresh cells appear to start in a healthier, homeostatic state.26PubMed Central. Enforced microglial depletion and repopulation as a promising strategy for the treatment of neurological disorders
This depletion-and-repopulation strategy has been tested in animal models of multiple sclerosis, Alzheimer’s disease, and other neuroinflammatory conditions with promising early results.27PubMed Central. Microglia depletion as a therapeutic strategy: friend or foe in multiple sclerosis models? The catch is timing and specificity. Removing microglia entirely, even temporarily, strips the brain of its immune surveillance. If an infection occurs during the depletion window, the brain has no first responder. And the new microglia that repopulate may not stay healthy forever if the underlying disease process that corrupted the original population is still active. Researchers are also investigating whether replacement cells could be provided from outside, essentially transplanting fresh microglia into a brain where the original population has been cleared. These approaches remain experimental, but they represent a fundamentally different strategy from traditional drug therapy: instead of trying to calm down sick cells, you swap them out.